CNMV Edison, 4 28006 Madrid

Barcelona (Spain), July 17, 2018

RELEVANT FACT

In accordance with the Royal Legislative Decree 4/2015, dated 23 October, which enacts the consolidated text of the Securities Market Act, and in relation to the Relevant Fact dated June 7, 2018 and registration number 266483 on the resolutions of the Board of Directors regarding the distribution of dividends through a scrip dividend, LABORATORIO REIG JOFRE SA ("Reig Jofre" or "the Company") hereby informs that:

  • ▪ Following the end of the trading period of the free allotment rights, as it was agreed by the General Shareholders' Meeting on May 3, 2018 and subsequent board of directors on June 6, 2018, the board of directors of the Company agreed on July 12, 2018 the ending of the process for the bonus-shares capital increase.

  • ▪ Concluded the trading period of the free allotment rights on June 29, 2018, 12,9% of the share capital requested the sale of rights to the Company, which will imply a distribution of cash dividend by the Company for a total amount of 380,110.47 euros. The settlement of the dividend shall be carried out on July 3, 2018.

  • ▪ 86.8% of Reig Jofre's share capital opted to receive new shares in payment of the flexible dividend.

  • ▪ Reig Jofre Investments SL, holder of 73% of Laboratorio Reig Jofre SA's share capital has informed the Company that:

    • - In order not to concentrate a greater shareholding in Reig Jofre and to facilitate the entry of new shareholders into Reig Jofre's shareholding base and, therefore, contribute to the increase of the Company's free float;

    • - In order not to retain 73% of the cash amount that would have been due to the sale of its rights to the Company and, thereby, to support the investment of said equity in the ongoing projects of the Company;

  • ▪ Reig Jofre Investments SL sold 100% of its free allotment rights among a group of private and institutional investors, without any of these placements implying a relevant stake over 3% by any of these investors. Thus, once the new shares are

    admitted to trading, Reig Jofre's first shareholder will place its shareholding of 72%.

  • ▪ Based on the resolutions adopted at those meetings, a public deed for the capital increase has been granted today. The conversion of the free allotment rights has given rise to a total of eight hundred and ninety-six thousand eight hundred and eighty-nine (896,889) new shares and, consequently, the capital stock of the Company will be increased in four hundred and forty-eight thousand four hundred and forty-four Euros and fifty cents (448,444.50).

  • ▪ As a result, Reig Jofre will request the listing of 896,889 new shares to be attributed to those shareholders who have opted for the exchange of rights for new shares within the scrip dividend.

  • ▪ The distribution of those shares and their admission to trading is scheduled to take place during the first half of August.

  • ▪ At that time, Reig Jofre's share capital will be established in thirty-two million, five

    hundred and twenty-five thousand and thirty-three Euros and fifty cents (32,525,033.50), represented by sixty-five million, fifty thousand and sixty-seven

    (65,050,067) standard shares with a par value of fifty cents (0.50) each, numbered consecutively from 1 to 65,050,067, both inclusive, all of which are fully subscribed and paid up.

Yours faithfully,

Adolf Rousaud

Secretary of the Board of Directors

Attachments

  • Original document
  • Permalink

Disclaimer

Laboratorio Reig Jofre SA published this content on 17 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 July 2018 06:06:09 UTC